Your browser is no longer supported. Please, upgrade your browser.
ASLN [NASD]
ASLAN Pharmaceuticals Limited
Index- P/E- EPS (ttm)-1.34 Insider Own- Shs Outstand37.99M Perf Week14.21%
Market Cap68.83M Forward P/E- EPS next Y-0.68 Insider Trans- Shs Float37.99M Perf Month5.34%
Income-45.70M PEG- EPS next Q-0.10 Inst Own10.70% Short Float0.03% Perf Quarter13.61%
Sales0.19M P/S362.83 EPS this Y-5.20% Inst Trans0.83% Short Ratio0.04 Perf Half Y19.89%
Book/sh-0.24 P/B- EPS next Y-74.40% ROA-190.20% Target Price- Perf Year-13.20%
Cash/sh0.46 P/C4.75 EPS next 5Y- ROE- 52W Range0.83 - 2.70 Perf YTD18.58%
Dividend- P/FCF- EPS past 5Y-14.80% ROI-283.20% 52W High-19.63% Beta-
Dividend %- Quick Ratio3.20 Sales past 5Y- Gross Margin- 52W Low161.45% ATR0.11
Employees- Current Ratio3.20 Sales Q/Q- Oper. Margin- RSI (14)63.22 Volatility5.95% 4.97%
OptionableNo Debt/Eq- EPS Q/Q59.70% Profit Margin- Rel Volume0.75 Prev Close2.14
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume329.07K Price2.17
Recom2.30 SMA2010.47% SMA5014.93% SMA20022.58% Volume247,869 Change1.40%
Jan-14-19Reiterated H.C. Wainwright Buy $12 → $8.50
Jan-11-21 05:34AM  
Jan-08-21 09:57AM  
Jan-06-21 11:13AM  
09:24AM  
Jan-04-21 09:34AM  
Dec-30-20 11:25AM  
Dec-25-20 12:00PM  
Dec-23-20 10:06AM  
Dec-22-20 10:27AM  
10:22AM  
Dec-21-20 10:13AM  
Dec-10-20 09:40AM  
Dec-03-20 10:04AM  
08:41AM  
Dec-02-20 06:03PM  
03:52PM  
Dec-01-20 10:06AM  
10:04AM  
08:30AM  
Nov-29-20 08:24PM  
Nov-27-20 08:25AM  
Nov-24-20 03:10PM  
03:08PM  
03:07PM  
Nov-19-20 07:22AM  
Nov-18-20 11:24AM  
11:13AM  
Nov-16-20 06:30AM  
Nov-09-20 07:00AM  
Oct-22-20 07:30AM  
Oct-19-20 10:05AM  
Oct-16-20 05:25AM  
Sep-21-20 06:00AM  
Sep-10-20 03:08AM  
Aug-24-20 03:27AM  
Aug-07-20 03:00AM  
Jul-17-20 06:08AM  
Jul-13-20 12:00PM  
08:06AM  
Jun-25-20 08:50AM  
Jun-19-20 05:50PM  
Jun-11-20 12:00PM  
Jun-04-20 09:46PM  
May-11-20 05:34AM  
May-07-20 05:50PM  
Apr-20-20 08:56AM  
Apr-13-20 04:21AM  
Mar-26-20 12:00PM  
Mar-18-20 05:18AM  
Feb-24-20 02:05AM  
Feb-20-20 05:50PM  
Feb-10-20 05:45PM  
Feb-04-20 05:45PM  
Jan-28-20 10:39AM  
Jan-27-20 11:30AM  
Jan-15-20 04:34PM  
08:22AM  
Jan-14-20 08:53AM  
Jan-13-20 12:00PM  
Jan-06-20 12:04PM  
Dec-18-19 09:58AM  
06:57AM  
Dec-05-19 06:22PM  
Dec-03-19 02:29PM  
07:59AM  
01:00AM  
Dec-02-19 01:34PM  
12:50PM  
07:51AM  
02:07AM  
Nov-22-19 08:18AM  
01:30AM  
Nov-11-19 12:36PM  
07:09AM  
03:21AM  
Nov-08-19 09:00AM  
Nov-06-19 11:00AM  
10:34AM  
Oct-31-19 03:37AM  
Oct-22-19 02:45AM  
Oct-18-19 03:35AM  
Oct-02-19 02:30AM  
Sep-30-19 02:35AM  
Sep-19-19 03:50AM  
Sep-10-19 05:14AM  
Aug-27-19 06:00AM  
Aug-13-19 04:03AM  
Jul-31-19 04:14AM  
Jul-26-19 04:20AM  
Jul-01-19 09:00AM  
Jun-04-19 08:00AM  
May-31-19 03:15AM  
May-10-19 04:15AM  
May-06-19 09:00AM  
Apr-29-19 05:02AM  
Mar-29-19 12:13PM  
05:50AM  
Mar-28-19 10:41AM  
Mar-22-19 07:25AM  
Mar-11-19 03:00AM  
ASLAN Pharmaceuticals Limited, a clinical-stage immunology and oncology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and a small molecule inhibitor targeting oncology. Its partners include Almirall, Array BioPharma, Bristol-Myers Squibb, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.